Fate Therapeutics Funding & Investors
Fate Therapeutics, Inc. provides biotechnology services. The Company researches and develops therapies to repair and regenerate body tissues with the help of stem cells. Fate Therapeutics conducts business in the United States.
fatetherapeutics.comTotal Amount Raised: $1,240,928,256
Fate Therapeutics Funding Rounds
Post Ipo Debt
$20,000,000
Post Ipo Debt Investors
Silicon Valley BankSeries Unknown
$9,200,000
Series B
$35,988,360
Series B Investors
Polaris PartnersAstellas Venture ManagementVenrockArch Venture PartnersOVP Venture PartnersDebt Financing
$1,000,000
Series B
$30,000,000
Series B Investors
Polaris PartnersAstellas Venture ManagementVenrockArch Venture PartnersSanofi VenturesOVP Venture PartnersSeries A
$12,000,000
Series A Investors
Polaris PartnersVenrockArch Venture PartnersOVP Venture PartnersPost Ipo Equity
$32,000,000
Post Ipo Equity
$8,000,000
Post Ipo Equity
$42,900,000
Post Ipo Equity
$56,749,988
Post Ipo Equity
$10,290,000
Post Ipo Equity
$172,500,000
Grant
$4,000,000
Grant Investors
California Institute for Regenerative MedicinePost Ipo Equity
$432,000,000
Post Ipo Equity
$201,300,000
Post Ipo Equity
$173,000,000
Post Ipo Equity
$173,000,000
Post Ipo Equity
$432,000,000
Post Ipo Equity
$201,300,000
Funding info provided by Diffbot.